common challenges glp-1 users weight loss drugs leave low on key nutrients, study finds GLP-1 Receptor Agonists | New

GLP-1 Drugs and Gastroparesis: What Victims Need to Know Key Takeaways Gastroparesis, or stomach paralysis, has emerged as a significant medical complication linked to GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro

Furthermore, exendin-4 lowered pain and serotonin in colon-sensitized rats with low GLP-1 levels [109]

But neither strategy is foolproof

What the pharmacokinetic research shows Eli Lilly published a Phase 1 study specifically examining tirzepatide absorption across all three injection sites

That said, Novo Nordisk and Eli Lilly aren't exactly sitting around doing nothing, so more GLP-1 developments are likely from this pair, as well